A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Determination of thyroid hormones in placenta using isotope-dilution liquid chromatography quadrupole time-of-flight mass spectrometry
Tekijät: Zhong-Min Li, Florian Giesert, Daniela Vogt-Weisenhorn, Katharina Maria Main, Niels Erik Skakkebæk, Hannu Kiviranta, Jorma Toppari, Ulla Feldt-Rasmussen, Heqing Shen, Karl-Werner Schramm, Meri De Angelisa
Kustantaja: Elsevier B.V.
Julkaisuvuosi: 2018
Journal: Journal of Chromatography A
Tietokannassa oleva lehden nimi: Journal of Chromatography A
Vuosikerta: 1534
Aloitussivu: 85
Lopetussivu: 92
Sivujen määrä: 8
ISSN: 0021-9673
DOI: https://doi.org/10.1016/j.chroma.2017.12.048
The transplacental passage of thyroid hormones (THs) is of great
significance since the maternal THs are vitally important in ensuring
the normal fetal development. In this paper, we determined the
concentrations of seven THs, viz. L-thyroxine (T4), 3,3′,5-triiodo-l-thyronine (T3), 3,3′,5′-triiodo-l-thyronine (rT3), 3,3′-diiodo-l-thyronine (T2), 3,5-diiodo-l-thyronine (rT2), 3-iodo-l-thyronine (T1) and 3-iodothyronamine (T1AM),
in placenta using isotope dilution liquid chromatography quadrupole
time-of-flight mass spectrometry. We optimized the method using
isotopically labeled quantification standards (13C6-T4, 13C6-T3, 13C6-rT3 and 13C6-T2) and recovery standard (13C12-T4)
in combination with solid-liquid extraction, liquid–liquid extraction
and solid phase extraction. The linearity was obtained in the range of
0.5–150 pg uL−1 with R2 values >0.99. The method detection limits (MDLs) ranged from 0.01 ng g−1 to 0.2 ng g−1, while the method quantification limits (MQLs) were between 0.04 ng g−1 and 0.7 ng g−1. The spike-recoveries for THs (except for T1 and T1AM)
were in the range of 81.0%–112%, with a coefficient of variation (CV)
of 0.5–6.2%. The intra-day CVs and inter-day CVs were 0.5%–10.3% and
1.19%–8.88%, respectively. Concentrations of the THs were 22.9–35.0 ng g−1 T4, 0.32–0.46 ng g−1 T3, 2.86–3.69 ng g−1 rT3, 0.16–0.26 ng g−1 T2, and < MDL for other THs in five human placentas, and 2.05–3.51 ng g−1 T4, 0.37–0.62 ng g−1 T3, 0.96–1.3 ng g−1 rT3, 0.07–0.13 ng g−1 T2 and < MDL for other THs in five mouse placentas. The presence of T2
was tracked in placenta for the first time. This method with improved
selectivity and sensitivity allows comprehensive evaluation of TH
homeostasis in research of metabolism and effects of environmental
contaminant exposures.